Members of the Infectious Diseases Society of America and its HIV Medicine Association across the country are on the front lines of COVID-19 responses in their communities. IDSA is proud to support their work in advancing research into COVID-19 and in development of data-driven, evidence-based research practices and responses. We offer these resources to help members of the public make informed decisions during this challenging time.
Clinicians: Visit the Real-Time Learning Network for expertly curated resources that will be updated daily for the frontline health care community.
Unwinding of COVID-19 Flexibilities and Waivers
IDSA has created resources to help clinicians understand the changes to the health care rules and regulations affected as policymakers shift out of the most acute phase of the COVID-19 pandemic, with most flexibilities and waivers announced for termination on May 11. A comprehensive list of guidance to the ending of the public health emergency can be found here.
IDSA COVID-19 Information and Safety Resources
- mRNA Vaccines: What to Know: Information for the public on safety of mRNA vaccines, with downloadable fact sheet.
- COVID-19 Bivalent Booster Vaccine FAQs: Answers to frequently asked questions about the bivalent COVID-19 boosters.
- COVID-19 Vaccine FAQ Information: Stay up to date on vaccine development and distribution planning.
- Guidelines and Guidance for COVID-19 Rapid and Antibody Testing: Collection of resources on diagnostic and antibody testing for containing COVID-19.
- Charitable Organizations Providing COVID-19 Relief Services: A directory compiled by IDSA.
- Science Speaks blog: IDSA/HIVMA’s global infectious diseases blog coverage of COVID-19 developments.
- Shareable Resources and Infographics:
IDSA Policy and Action for COVID-19
- Equitable Access to COVID-19 Antiviral Treatments: IDSA statement urging the federal government to take steps to ensure equitable access to people who may be most in need of antiviral treatment but may not be receiving it because of where they live.
- Are We Prepared for Another Pandemic? ID experts play a critical role in bio preparedness – not only aiding in the current COVID-19 response but also preparing us for the next pandemic. Congress is currently considering legislation, like the Biopreparedness Workforce Act, to support necessary investments ensuring that we are ready to address future health threats efficiently and effectively.
- Addressing Health Disparities in the Impact of COVID-19: COVID-19 has had a disparate impact on several communities, including the Black/African American, Native American and rural communities. See IDSA policy recommendations for addressing these disparities.
